drugset / Trial / NCT03635827
Xenon Inhalation for Treatment of Posttraumatic Stress Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a double-blind, randomized, placebo-controlled, clinical trial in parallel groups in patients with PTSD.
Timeline
- Start
- 2021-06
- Primary completion
- 2021-06
- Completion
- 2021-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Xenon | Other / unclassified | 10 unknown | Inhaled |